Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Organon (OGN) Outperforms Broader Market: What You Need to Know
06:50pm, Monday, 29'th Sep 2025
Organon (OGN) reached $10.35 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.
Here's Why Organon (OGN) Fell More Than Broader Market
07:01pm, Thursday, 25'th Sep 2025
Organon (OGN) closed the most recent trading day at $10.12, moving 2.79% from the previous trading session.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
10:01am, Wednesday, 24'th Sep 2025
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Orogen Royalties' Exploration Stage Project and Royalty Update
07:30am, Wednesday, 24'th Sep 2025
VANCOUVER, BC / ACCESS Newswire / September 24, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage
Organon (OGN) Stock Dips While Market Gains: Key Facts
06:51pm, Friday, 19'th Sep 2025
In the closing of the recent trading day, Organon (OGN) stood at $10.45, denoting a -3.69% move from the preceding trading day.
SHANGHAI & JERSEY CITY, N.J.--(BUSINESS WIRE)--European Commission Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 12'th Sep 2025
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
Organon (OGN) Stock Declines While Market Improves: Some Information for Investors
06:51pm, Wednesday, 10'th Sep 2025
Organon (OGN) concluded the recent trading session at $10.26, signifying a -1.06% move from its prior day's close.
Kuehn Law Encourages Investors of Organon & Co. to Contact Law Firm
11:27am, Tuesday, 09'th Sep 2025
NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Organon & Co. (NYSE: OGN) breached their fiduc
Orogen Royalties Announces Trading on the OTCQB
07:30am, Monday, 08'th Sep 2025
VANCOUVER, BC / ACCESS Newswire / September 8, 2025 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce its shares have been qualified to begin trading o
Orogen Royalties and South32 Form Generative Base Metals Alliance
07:30am, Thursday, 04'th Sep 2025
All dollar figures expressed in United States dollars unless otherwise stated VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / (TSXV:OGN)(OTC:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Compan
SHANGHAI & JERSEY CITY, N.J.--(BUSINESS WIRE)--FDA Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp).
Orogen Royalties Reports Q2 2025 Financial Results Based on Carve-out Financial Statements
07:30am, Tuesday, 26'th Aug 2025
VANCOUVER, BC / ACCESS Newswire / August 26, 2025 / (TSXV:OGN)(OTC:OGNNF) Orogen Royalties Inc. (formerly 1537944 BC Ltd.) ("Orogen" or the "Company") is pleased to announce strong revenue and cash fl
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 25'th Aug 2025
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
NYSE: OGN Lawsuit Alert: Investors who lost money with Organon & Co. (NYSE: OGN) shares should contact the Shareholders Foundation
10:15am, Wednesday, 13'th Aug 2025
SAN DIEGO , Aug. 13, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of Organon & Co. (NYSE: OGN). Investors who purchased sha
